Pemzek PLUS 32/12.5 mg, Tabletten - 98 Tablette(n) Swissmedic Key 62499006 Registration Holder AstraZeneca AG Name Pemzek PLUS 32/12.5 mg, Tabletten Date of registration 06.01.2012 Original/Generic Original Introduction of Sequence 06.01.2012 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 37.38 Limitation No Deductible 10 % Consumer price 56.90 Feedback FB GTIN 7680624990067 Medication Code Synthetika Pharmacode 5259004 Disponibility
Composition candesartanum cilexetilum 32 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 148.5 mg, magnesii stearas, maydis amylum, macrogolum, E 172 (flavum), pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 32 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Calcicum E 172 color. Hydroxypropylcellulosum Lactose Monohydrate 148.5 mg Macrogol Magnesii Stearas Maydis Amylum Pro Compresso
Source Data was imported : 06.09.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
